Product Information
Treatment of neovascular (wet) age-related macular degeneration (AMD). Treatment of diabetic macular edema (DME)
Active Ingredients - Brolucizumab
Product Division - Novartis Pharmaceuticals
Subcategory - Anti-VEGF
Vsiqq(Brolucizumab)
Products
Below is a list of the treatments we currently offer via our Innovative Medicines Division.
Please note: Not all treatments are available in all countries.